TheraRadar
Data updated: May 26, 2026

PHENYLEPHRINE HYDROCHLORIDE

Cardiovascular Approved 2012-12-20

Phenylephrine hydrochloride helps patients with significant drops in blood pressure that occur while under anesthesia. It is used when blood vessels widen excessively, leading to a condition known as clinically important hypotension. This medication helps stabilize the patient's circulatory system during surgical procedures.

Source: FDA Label • MEITHEAL

How PHENYLEPHRINE HYDROCHLORIDE Works

This medication works by acting as an alpha-1 adrenergic receptor agonist. By binding to these specific receptors, it triggers a response that counteracts vasodilation to help restore normal blood pressure levels.

28
Indications
--
Phase 3 Trials
1
Priority Reviews
13
Years on Market

PHENYLEPHRINE HYDROCHLORIDE Approval History

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
120 FDA actions from 2012 to 2026
Apr 2026 ORIGINAL
Update
Sep 2025 SUPPL
Mfg · Manufacturing (CMC)
Feb 2025 ORIGINAL
Update

What PHENYLEPHRINE HYDROCHLORIDE Treats

1 indications

PHENYLEPHRINE HYDROCHLORIDE is approved for 1 conditions since its original approval in 2012. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Hypotension
Source: FDA Label

PHENYLEPHRINE HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 10 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to PHENYLEPHRINE HYDROCHLORIDE

3 of 16

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ADRENACLICK
EPINEPHRINE
1 shared
IMPAX
Shared indications:
ADRENALIN
EPINEPHRINE
1 shared
PH HEALTH
Shared indications:
AKOVAZ
EPHEDRINE SULFATE
1 shared
EXELA PHARMA
Shared indications:
📋

Clinical Trial Registry

2 trials
Trial Sponsor ID Phase Status Title
NCT05997732 STARS Pro00126600 Ph 4 recruiting Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
NCT03098680 PRIME PRIME (A094136) Ph 1 terminated A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PHENYLEPHRINE HYDROCHLORIDE FDA Label Details

Indications & Usage

FDA Label (PDF)

PHENYLEPHRINE HYDROCHLORIDE is indicated for the treatment of Hypotension.

View full patent landscape →
4 OB patents · 2 families · 12 international docs across 2 countries

PHENYLEPHRINE HYDROCHLORIDE Patents & Exclusivity

Latest Patent: Sep 2036

Patents (4 active)

US11213480 Expires Sep 26, 2036
US12257342 Expires Sep 26, 2036
US11471400 Expires Aug 5, 2036
US8859623 Expires Nov 14, 2033
Source: FDA Orange Book

Pro Intelligence Preview

Deep insights for PHENYLEPHRINE HYDROCHLORIDE

Revenue Insights

  • Quarterly revenue tracking
  • Historical trend analysis

Patent Timeline

  • Cliff: 2036
  • 22 active patents

Trial Analysis

  • Clinical trial tracking
  • Development stage analysis

Competitive Landscape

  • 16 similar drugs
  • Same target/indication analysis
Unlock Full Intelligence

Full approval history • All patents • Revenue trends • Competitor analysis

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.